Stat3 Therapeutics Enlists Zer0 to 5ive for Brand and Messaging Development

Stat3 Therapeutics is an early-stage drug development company that is focused on developing and commercializing a drug that targets and blocks the Stat3 molecule, a protein closely associated with cancer.   In preparation for market entry, Zer0 to 5ive will assist Stat3 in developing their brand identity, logo, company and product positioning, as well as key messages to target audiences.

Comments are closed.